MedTrace Logo

Tyrosur® Gel-Investigation on Wound Healing Efficacy

NCT01227759 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2010-10-26

No results posted yet for this study

Summary

This IIa study with intraindividual comparison of treated versus untreated to assess the wound healing efficacy of Tyrosur® Gel after experimental impairment of the skin using an abrasive wound healing model.

Conditions

  • Wounds
  • Wound Healing

Interventions

DRUG

Drug containing the active ingredient

The topical application is performed once daily during a 12-day treatment.

DRUG

Placebo

Placebo containing no active ingredient

Sponsors & Collaborators

  • Engelhard Arzneimittel GmbH & Co.KG

    lead INDUSTRY

Principal Investigators

  • Walter Wigger-Alberti, MD · Managing director bioskin, Hamburg Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2010-10-31
Completion
2010-10-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01227759 on ClinicalTrials.gov